The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empirical Model Building and Response Surfaces
Freeny, A. (1988) · Technometrics · doi:10.1080/00401706.1988.10488371 · Cited by 5,235
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Some suggestions for measuring predictive performance
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060893 · Cited by 1,617
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253358 · Cited by 1,134
Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
Anderson, B. J., & Holford, N. H. G. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094708 · Cited by 1,125
Ways to Fit a PK Model with Some Data Below the Quantification Limit
Beal, S. L. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1012299115260 · Cited by 1,114
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Mould, D., & Upton, R. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.14 · Cited by 897
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
DiMasi, J. A., Feldman, L., Seckler, A., & Wilson, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.295 · Cited by 845
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Ambrose, P. G., Bhavnani, S. M., Rubino, C. M., Louie, A., Gumbo, T., Forrest, A., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510079 · Cited by 697
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials
Preston, S. L. (1998) · JAMA · doi:10.1001/jama.279.2.125 · Cited by 589
Pharmacokinetic-Pharmacodynamic Modeling and Simulation
Bonate, P. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9485-1 · Cited by 572
Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H., & Drusano, G. L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki079 · Cited by 549
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development
Mould, D., & Upton, R. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.4 · Cited by 544
Karlsson, M. O., & Savic, R. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100241 · Cited by 541
Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs
Friberg, L. E., Henningsson, A., Maas, H., Nguyen, L., & Karlsson, M. O. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.140 · Cited by 534
Self-citationThomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H., & Schentag, J. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.521 · Cited by 507
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Self-citationThe importance of modeling interoccasion variability in population pharmacokinetic analyses
Karlsson, M. O., & Sheiner, L. B. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01113502 · Cited by 485
Blaser, J., Stone, B. B., Groner, M. C., & Zinner, S. H. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1054 · Cited by 481
The FDA Critical Path Initiative and Its Influence on New Drug Development
Woodcock, J., & Woosley, R. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.090506.155819 · Cited by 434
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
Drusano, G. L., Johnson, D. E., Rosen, M., & Standiford, H. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.483 · Cited by 426
Animal model pharmacokinetics and pharmacodynamics: a critical review
Andes, D., & Craig, W. A. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00022-5 · Cited by 413
Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check
Yano, Y., Beal, S. L., & Sheiner, L. B. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1011555016423 · Cited by 407
Zhao, X., & Drlica, K. (2001) · Clinical Infectious Diseases · doi:10.1086/321841 · Cited by 397
Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria
Kashuba, A. D. M., Nafziger, A. N., Drusano, G. L., & Bertino, J. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.623 · Cited by 380 · cited 3×
“Other examples of variables that have been used to determine antibacterial efficacy include time to bacterial eradication, time to body-temperature resolution, and time to leukocyte count resolution, see e.g., Kashuba et al. (1999).”
BackgroundMethodClinical pharmacokinetics and phamacodynamics: concepts and applications
Rowland, M., & Tozer, T. N. (2011) · Cited by 367
Leggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W., Mattie, H., & Craig, W. A. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.281 · Cited by 354
Diversity of Mechanism-Based Pharmacodynamic Models
Mager, D. E., Wyska, E., & Jusko, W. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.510 · Cited by 345
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
Schmidt, S., Gonzalez, D., & Derendorf, H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21916 · Cited by 335
Optimal sampling times for pharmacokinetic experiments
D'Argenio, D. Z. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01070904 · Cited by 324
Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
Marcusson, L. L., Frimodt-Møller, N., & Hughes, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000541 · Cited by 320
Gumbo, T., Louie, A., Deziel, M. R., Parsons, L. M., Salfinger, M., & Drusano, G. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/424849 · Cited by 315
Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00007 · Cited by 306
Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC
Mueller, M., de la Peña, A., & Derendorf, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.369-377.2004 · Cited by 304
Ambrose, P. G., Grasela, D. M., Grasela, T. H., Passarell, J., Mayer, H. B., & Pierce, P. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2793-2797.2001 · Cited by 299
Berezhkovskiy, L. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20073 · Cited by 296
Holford, N. H. G., Kimko, H. C., Monteleone, J. P. R., & Peck, C. C. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.209 · Cited by 289
Dacey, R. G., & Sande, M. A. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.4.437 · Cited by 287
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
DANHOF, M., DELANGE, E., DELLAPASQUA, O., PLOEGER, B., & VOSKUYL, R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.007 · Cited by 287
Mouton, J. W., Brown, D. F. J., Apfalter, P., Cantón, R., Giske, C. G., Ivanova, M., MacGowan, A. P., Rodloff, A., Soussy, C.-J., Steinbakk, M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03752.x · Cited by 286
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 264
Nielsen, E. I., Cars, O., & Friberg, L. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00182-11 · Cited by 254
Self-citationFunctional relationship between bacterial cell density and the efficacy of antibiotics
Udekwu, K. I., Parrish, N., Ankomah, P., Baquero, F., & Levin, B. R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn554 · Cited by 250
Protein Binding: Do We Ever Learn?
Zeitlinger, M. A., Derendorf, H., Mouton, J. W., Cars, O., Craig, W. A., Andes, D., & Theuretzbacher, U. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01433-10 · Cited by 249
Dalfino, L., Puntillo, F., Mosca, A., Monno, R., Spada, M. L., Coppolecchia, S., Miragliotta, G., Bruno, F., & Brienza, N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis286 · Cited by 247
Drusano, G. L., Preston, S. L., Hardalo, C., Hare, R., Banfield, C., Andes, D., Vesga, O., & Craig, W. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.13-22.2001 · Cited by 243
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
Craig, W. A., Redington, J., & Ebert, S. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.29 · Cited by 238
Jumbe, N., Louie, A., Leary, R., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Freeman, C., Kahn, J. B., Bush, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16814 · Cited by 238
Jumbe, N., Louie, A., Leary, R., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Freeman, C., Kahn, J. B., Bush, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316814 · Cited by 236
Mohamed, A. F., Karaiskos, I., Plachouras, D., Karvanen, M., Pontikis, K., Jansson, B., Papadomichelakis, E., Antoniadou, A., Giamarellou, H., Armaganidis, A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06426-11 · Cited by 234
Self-citationEagle, H., Fleischman, R., & Levy, M. (1953) · New England Journal of Medicine · doi:10.1056/nejm195303192481201 · Cited by 230
Dudhani, R. V., Turnidge, J. D., Coulthard, K., Milne, R. W., Rayner, C. R., Li, J., & Nation, R. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01114-09 · Cited by 205
Zuluaga, A. F., Salazar, B. E., Rodriguez, C. A., Zapata, A. X., Agudelo, M., & Vesga, O. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-55 · Cited by 202
Mouton, J. W., Ambrose, P. G., Canton, R., Drusano, G. L., Harbarth, S., MacGowan, A., Theuretzbacher, U., & Turnidge, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.005 · Cited by 200
Effect of schedule of administration on the therapeutic efficacy of penicillin
Eagle, H., Fleischman, R., & Musselman, A. D. (1950) · The American Journal of Medicine · doi:10.1016/0002-9343(50)90425-6 · Cited by 197
Austin, D. J., & Anderson, R. M. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0425 · Cited by 195
Clinical Trial Simulation: A Review
Holford, N., Ma, S. C., & Ploeger, B. A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.114 · Cited by 191
Grasso, S., Meinardi, G., De Carneri, I., & Tamassia, V. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.4.570 · Cited by 188
Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations
Liu, P., Müller, M., & Derendorf, H. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00024-9 · Cited by 186
Murine model of cutaneous infection with gram-positive cocci
Bunce, C., Wheeler, L., Reed, G., Musser, J., & Barg, N. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2636-2640.1992 · Cited by 186
De Paepe, P., Belpaire, F. M., & Buylaert, W. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00002 · Cited by 181
Kugelberg, E., Norström, T., Petersen, T. K., Duvold, T., Andersson, D. I., & Hughes, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3435-3441.2005 · Cited by 180
Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1371-1375.2003 · Cited by 177
Animal models of external traumatic wound infections
Dai, T., Kharkwal, G. B., Tanaka, M., Huang, Y.-Y., Bil de Arce, V. J., & Hamblin, M. R. (2011) · Virulence · doi:10.4161/viru.2.4.16840 · Cited by 175
Nielsen, E. I., Viberg, A., Löwdin, E., Cars, O., Karlsson, M. O., & Sandström, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00604-06 · Cited by 172
Self-citationBergen, P. J., Bulitta, J. B., Forrest, A., Tsuji, B. T., Li, J., & Nation, R. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00903-09 · Cited by 166
Jusko, W. J. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600618 · Cited by 160
Blaser, J. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.suppl_a.125 · Cited by 158
Accelerating resistance, inadequate antibacterial drug pipelines and international responses
Theuretzbacher, U. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.006 · Cited by 157
Mouton, J. W., & Vinks, A. A. T. M. M. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544020-00005 · Cited by 157
Pharmacometrics : the science of quantitative pharmacology
Ette, E., & Williams, P. J. (2007) · Wiley eBooks · doi:10.1002/0470087978 · Cited by 151
Barrett, J. S., Fossler, M. J., Cadieu, K. D., & Gastonguay, M. R. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008315318 · Cited by 145
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 144
Mouton, J. W., Vinks, A. A. T. M. M., & Punt, N. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.733 · Cited by 142
Sasaki, T., Takane, H., Ogawa, K., Isagawa, S., Hirota, T., Higuchi, S., Horii, T., Otsubo, K., & Ieiri, I. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01185-10 · Cited by 138
Modelling time–kill studies to discern the pharmacodynamics of meropenem
Tam, V. H., Schilling, A. N., & Nikolaou, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki086 · Cited by 134
Natural history of aortic valve endocarditis in rats
Héraïef, E., Glauser, M. P., & Freedman, L. R. (1982) · Infection and Immunity · doi:10.1128/iai.37.1.127-131.1982 · Cited by 129
An adaptive grid non-parametric approach to pharmacokinetic and dynamic (PK/PD) population models
Leary, R. H., Jelliffe, R. W., Schumitzky, A., & Guilder, M. V. (2002) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2001.941750 · Cited by 124
Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects
Czock, D., & Keller, F. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9069-x · Cited by 118
Gerber, A., Brugger, H. P., Feller, C., et al. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.1.90 · Cited by 114
In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin
Andes, D. R., & Craig, W. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01264-06 · Cited by 114
Jansson, B., Karvanen, M., Cars, O., Plachouras, D., & Friberg, L. E. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.12.016 · Cited by 110
Self-citationMatthews, I., Kirkpatrick, C. M. J., & Holford, N. H. G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02114.x · Cited by 110
Study designs for dose-ranging
Sheiner, L. B., Beal, S. L., & Sambol, N. C. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.108 · Cited by 109
Target concentration intervention: beyond Y2K
Holford, N. H. G. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00971.x · Cited by 109
Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo Model
Gerber, A., Vastola, A. P., Brandel, J., et al. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.5.691 · Cited by 108
Aminoglycoside Nephrotoxicity: Modeling, Simulation, and Control
Rougier, F., Claude, D., Maurin, M., Sedoglavic, A., Ducher, M., Corvaisier, S., Jelliffe, R. W., & Maire, P. H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1010-1016.2003 · Cited by 105
Tam, V. H., Louie, A., Deziel, M. R., Liu, W., Leary, R. H., & Drusano, G. L. (2005) · The Journal of Infectious Diseases · doi:10.1086/430611 · Cited by 104
Bhavnani, S. M., Rubino, C. M., Hammel, J., Forrest, A., Dartois, N., Cooper, C. A., Korth-Bradley, J. M., & Ambrose, P. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01615-10 · Cited by 103
In vitro pharmacodynamic models to determine the effect of antibacterial drugs
Gloede, J., Scheerans, C., Derendorf, H., & Kloft, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp434 · Cited by 103
Infectious Diseases Society of America (IDSA) (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis688 · Cited by 103
(2002) · Annals of the ICRP · doi:10.1016/s0146-6453(02)00021-0 · Cited by 99
Mould, D. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.122 · Cited by 94
Mohamed, A. F. S., Nielsen, E. I., Cars, O., & Friberg, L. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00694-11 · Cited by 93
Self-citationBulitta, J. B., Ly, N. S., Yang, J. C., Forrest, A., Jusko, W. J., & Tsuji, B. T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00489-08 · Cited by 93
Ahmed, A. I., Jafri, H. S., Lutsar, I., McCoig, C. C., Trujillo, M., Wubbel, L., Shelton, S., & McCracken, G. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.876 · Cited by 89
Frimodt-Meller, N., Bentzen, M. W., & Thomsen, V. F. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/154.3.511 · Cited by 88
Application of Logistic Growth Model to Pharmacodynamic Analysis of in Vitro Bactericidal Kinetics
Yano, Y., Oguma, T., Nagata, H., & Sasaki, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9801337 · Cited by 86
Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model
Drusano, G. L., Fregeau, C., Liu, W., Brown, D. L., & Louie, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00133-10 · Cited by 84
Drusano, G. L., Sgambati, N., Eichas, A., Brown, D. L., Kulawy, R., & Louie, A. (2010) · mBio · doi:10.1128/mbio.00139-10 · Cited by 82
Björkman, S. E., Wada, D., Berling, B., & Benoni, G. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1076 · Cited by 80
Zhi, J., Nightingale, C. H., & Quintiliani, R. (1988) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062551 · Cited by 80
Meagher, A. K., Forrest, A., Dalhoff, A., Staß, H., & Schentag, J. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2061-2068.2004 · Cited by 79
Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole
Rodvold, K., Nicolau, D., Lodise, T., Khashab, M., Noel, G., Kahn, J., Gotfried, M., Murray, S., Nicholson, S., Laohavaleeson, S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00144-09 · Cited by 78
Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid
Rodvold, K. A., Yoo, L., & George, J. M. (2011) · Clinical Pharmacokinetics · doi:10.2165/11592900-000000000-00000 · Cited by 75
Lutsar, I., Friedland, I. R., Wubbel, L., McCoig, C. C., Jafri, H. S., Ng, W., Ghaffar, F., & McCracken, G. H. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2650 · Cited by 75
Clinical Pharmacokinetics and Pharmacodynamics
(2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-9979-6.00231-2 · Cited by 75
Cho, J. S., Zussman, J., Donegan, N. P., Ramos, R. I., Garcia, N. C., Uslan, D. Z., Iwakura, Y., Simon, S. I., Cheung, A. L., Modlin, R. L., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.417 · Cited by 73
Semiparametric Distributions With Estimated Shape Parameters
Petersson, K., Hanze, E., Savić, R. M., & Karlsson, M. O. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9931-1 · Cited by 70
Lutsar, I., Ahmed, A. I., Friedland, I. R., Trujillo, M., Wubbel, L., Olsen, K. D., & McCracken, G. H. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2414 · Cited by 69
Sandström, M., Lindman, H., Nygren, P., Johansson, M., Bergh, J. C. S., & Karlsson, M. O. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0140-2 · Cited by 68
HANDBOOK OF ANIMAL MODELS OF INFECTION: EXPERIMENTAL MODELS IN ANTIMICROBIAL CHEMOTHERAPY
Zak, O., & Sande, M. E. (2000) · Shock · doi:10.1097/00024382-200003000-00016 · Cited by 67
Knudsen, J. D., Frimodt‐Møller, N., & Espersen, F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1253 · Cited by 67
Highet, V. S., Forrest, A., Ballow, C. H., & Schentag, J. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.suppl_1.55 · Cited by 63
Friberg, L. E., de Greef, R., Kerbusch, T., & Karlsson, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.44 · Cited by 63
Self-citationLiu, P., Rand, K. H., Obermann, B., & Derendorf, H. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.012 · Cited by 59
Will new antimicrobials overcome resistance among Gram-negatives?
Bassetti, M., Ginocchio, F., Mikulska, M., Taramasso, L., & Giacobbe, D. R. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.107 · Cited by 58
Experimental Endocarditis Due to Pseudomonas aeruginosa. I. Description of a Model
Archer, G. L., & Fekety, F. R. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/134.1.1 · Cited by 57
Zhi, J., Nightingale, C. H., & Quintiliani, R. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751108 · Cited by 56
Harigaya, Y., Bulitta, J. B., Forrest, A., Sakoulas, G., Lesse, A. J., Mylotte, J. M., & Tsuji, B. T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01585-08 · Cited by 54
Laohavaleeson, S., Tessier, P., & Nicolau, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01422-07 · Cited by 50
A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc
Rosario, M., Jacqmin, P., Dorr, P., et al. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.07.010 · Cited by 49
Piroth, L., Martin, L., Coulon, A., Lequeu, C., Duong, M., Buisson, M., Portier, H., & Chavanet, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2484 · Cited by 49
Khachman, D., Conil, J., Georges, B., Saivin, S., Houin, G., Toutain, P., & Laffont, C. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr220 · Cited by 48
Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model
Friberg, L. E., Sandström, M., & Karlsson, M. O. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9308-7 · Cited by 45
Self-citationVong, C., Bergstrand, M., Nyberg, J., & Karlsson, M. O. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9327-8 · Cited by 45
Harnisch, L. O., Matthews, I., Chard, J., & Karlsson, M. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.10 · Cited by 44
Nielsen, E. I., Cars, O., & Friberg, L. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01286-10 · Cited by 44
Self-citationKatsube, T., Yamano, Y., & Yano, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21062 · Cited by 43
Gibiansky, L. V., Gibiansky, E., & Bauer, R. J. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9228-y · Cited by 43
Bakker‐Woudenberg, I. A. J. M., van den Berg, J. C., & MICHEL, M. F. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.6.1042 · Cited by 43
Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia Model
Guo, B., Abdelraouf, K., Ledesma, K. R., Chang, K., Nikolaou, M., & Tam, V. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00508-11 · Cited by 43
The Effect of Critical Illness on Drug Distribution
González, D., Conrado, D. J., Theuretzbacher, U., & Derendorf, H. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808211 · Cited by 40
Keel, R. A., Crandon, J. L., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00372-11 · Cited by 40
Huisinga, W., Solms, A., Fronton, L., & Pilari, S. (2012) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.3 · Cited by 40
Schuck, E. L., Dalhoff, A., Stass, H., et al. (2005) · Infection · doi:10.1007/s15010-005-8204-0 · Cited by 37
Nicasio, A. M., Bulitta, J. B., Lodise, T. P., D'Hondt, R. E., Kulawy, R., Louie, A., & Drusano, G. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05664-11 · Cited by 35
Adiwijaya, B. S., Kieffer, T. L., Henshaw, J., Eisenhauer, K. M., Kimko, H. H. C., Alam, J. J., Kauffman, R. S., & Garg, V. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002339 · Cited by 33
Marshall, S. F., Macintyre, F., James, I., Krams, M., & Jonsson, E. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645020-00004 · Cited by 32
Ambrose, P. G., Hammel, J., Bhavnani, S. M., Rubino, C. M., Ellis‐Grosse, E. J., & Drusano, G. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01743-10 · Cited by 30
Time for Quantitative Clinical Pharmacology: A Proposal for a Pharmacometrics Curriculum
Holford, N. H. G., & Karlsson, M. O. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100231 · Cited by 28
Blatter, M., Flückiger, U. M., Entenza, J. M., Glauser, M. P., & Francioli, P. B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1971 · Cited by 28
Clinical pharmacology as a cornerstone of orphan drug development
Bashaw, E. D., Huang, S. M., Coté, T. R., Pariser, A., Garnett, C. E., Burckart, G. J., Zhang, L., Men, A. Y., Le, C. D., Charlab, R., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3595 · Cited by 27
Katsube, T., Yano, Y., Yamano, Y., Munekage, T., Kuroda, N., & Takano, M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21265 · Cited by 27
Schmidt, S., Sabarinath, S., Barbour, A., Abbanat, D., Manitpisitkul, P., Sha, S., & Derendorf, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-09 · Cited by 26
In Vivo Pharmacodynamics of New Lipopeptide MX-2401
Craig, W. A., Andes, D. R., & Stamstad, T. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-10 · Cited by 24
Azoulay-Dupuis, E., Bédos, J. P., Mohler, J., Moine, P., Cherbuliez, C., Peytavin, G., Fantin, B., & Köhler, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1046-1054.2005 · Cited by 24
Wright, A. J., Wilson, W. R., Matsumoto, J. Y., Washington, J. A., & GERACI, J. E. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.6.972 · Cited by 23
Gupta, P. K., Friberg, L. E., Karlsson, M. O., Krishnaswami, S., & French, J. L. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009346060 · Cited by 21
Self-citationAlemayehu, D., Quinn, J. P., Cook, J., Kunkel, M. J., & Knirsch, C. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis503 · Cited by 19
Pharmacometrics for Regulatory Decision Making
Manolis, E., & Herold, R. (2011) · Clinical Pharmacokinetics · doi:10.2165/11594340-000000000-00000 · Cited by 18
Knudsen, J. D. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.4.451 · Cited by 17
Cited by
Nicoloff, H., Hjort, K., Levin, B. R., & Andersson, D. I. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0342-0 · Cited by 401
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Dartois, V. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3200 · Cited by 388
From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics
Wicha, S. G., Märtson, A., Nielsen, E. I., Koch, B. C. P., Friberg, L. E., Alffenaar, J., Minichmayr, I. K., & the International Society of Anti‐Infective Pharmacology (ISAP), T. P. S. G. O. T. E. S. O. C. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2202 · Cited by 322
Self-citationRoell, K. R., Reif, D. M., & Motsinger-Reif, A. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00158 · Cited by 295
Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation
Fourches, D., Muratov, E., & Tropsha, A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00129 · Cited by 294
Metadata
- Authors
- Nielsen, E. I., & Friberg, L. E.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 65
- Issue
- 3
- Pages
- 1053-1090
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W1982462000
- Cited by
- 332
- References
- 165
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.